Japan Peptide Synthesis Market Size & Outlook, 2025-2033
- Biotechnology
- Proteomics & Protein Analysis
- Peptide Synthesis Market Outlook
- Proteomics & Protein Analysis
Global Market
Related Markets
Ask a question about the peptide synthesis market
Japan peptide synthesis market highlights
- The Japan peptide synthesis market generated a revenue of USD 53.3 million in 2024 and is expected to reach USD 112.2 million by 2033.
- The Japan market is expected to grow at a CAGR of 9% from 2025 to 2033.
- In terms of segment, reagents & consumables was the largest revenue generating product in 2024.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
Peptide synthesis market data book summary
| Market revenue in 2024 | USD 53.3 million |
| Market revenue in 2033 | USD 112.2 million |
| Growth rate | 9% (CAGR from 2025 to 2033) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Equipment |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Consumables, Equipment, Service |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GenScript, Bachem Holding AG, Biotage, Creative Diagnostics, PolyPeptide Group AG, Syngene, Lonza |
Other key industry trends
- In terms of revenue, Japan accounted for 5.5% of the global peptide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China peptide synthesis market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 71.3 million by 2033.
The Japan peptide synthesis market is witnessing significant growth over the forecast period, driven by advancements in pharmaceutical research, increased investment in biotechnology, and a growing focus on peptide-based therapeutics to address chronic and age-related diseases. For instance, in May 2023, SynCrest Inc., a joint venture between Otsuka Chemical Co., Ltd. and Yokogawa Electric Corporation, launched its Contract Research, Development, and Manufacturing Organization (CRDMO) services for peptide-based therapeutics.
The company offers integrated support across the drug development value chain, utilizing advanced continuous flow synthesis with in-line measurement. The company's manufacturing facilities are located at the Naruto Plant in Tokushima, Japan, which is GMP-compliant for highly potent substances and includes both GMP and non-GMP areas to enable a diverse and flexible production system, further expanding production of peptides in the country.
No credit card required*
Publish Date: Jun 23, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Synthesis Market Scope
Peptide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| PolyPeptide Group AG | View profile | 1,273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | www.polypeptide.com |
| Bachem Holding AG | View profile | 2,006 | Hauptstrasse 144, Bubendorf, Switzerland, 4416 | www.bachem.com |
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | www.creative-diagnostics.com |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | www.syngeneintl.com |
| Biotage | View profile | 501-1000 | Uppsala, Uppsala Lan, Sweden, Europe | www.biotage.com |
| GenScript | View profile | - | - | - |
| Lonza | View profile | - | - | - |
Japan Peptide Synthesis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Peptide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Reagents & Consumables was the largest segment with a revenue share of 46.72% in 2024.
Horizon Databook has segmented the Japan peptide synthesis market based on reagents & consumables, equipment, service covering the revenue growth of each sub-segment from 2021 to 2033.
The Japan peptide synthesis market is witnessing significant growth over the forecast period, driven by advancements in pharmaceutical research, increased investment in biotechnology, and a growing focus on peptide-based therapeutics to address chronic and age-related diseases. For instance, in May 2023, SynCrest Inc., a joint venture between Otsuka Chemical Co., Ltd. and Yokogawa Electric Corporation, launched its Contract Research, Development, and Manufacturing Organization (CRDMO) services for peptide-based therapeutics.
The company offers integrated support across the drug development value chain, utilizing advanced continuous flow synthesis with in-line measurement. The company's manufacturing facilities are located at the Naruto Plant in Tokushima, Japan, which is GMP-compliant for highly potent substances and includes both GMP and non-GMP areas to enable a diverse and flexible production system, further expanding production of peptides in the country.
- Japan Peptide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Reagents & Consumables
- Equipment
- Service
- Japan Peptide Synthesis Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
- Hybrid Technology
- Japan Peptide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutics
- Research
- Diagnosis
- Japan Peptide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- CDMOs & CROs
- Academic & Research Institutes
Reasons to subscribe to Peptide Synthesis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Peptide Synthesis Market Outlook databook
- Our clientele includes a mix of Peptide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Peptide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Peptide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Peptide Synthesis Market, 2021-2033 (US$M)
Japan peptide synthesis market statistics, by product, 2021-2033 (US$M)
